Topoisomerase inhibitors still matter in oncology research, screening projects, and controlled drug supply. This guide covers the basic mechanism, common compounds, sourcing checks, and public data points buyers should review before placing…

Angiogenesis inhibitors block blood vessel signals that many tumors rely on for growth. This guide covers working mechanisms, key data checks, sourcing points, and common risks for research and chemical buyers.

Checkpoint inhibitors are a core part of cancer immunotherapy. This article explains PD-1, PD-L1, CTLA-4, and LAG-3 in plain trade language, with notes on public data, sourcing checks, documents, and safe research…

Tyrosine inhibitors are still useful tools for kinase pathway work, but the result depends on target match, assay setup, compound quality, and batch paperwork.

A plain trade-focused guide to CDK 4/6 inhibitor mechanisms, approved agents, clinical data, safety points, and sourcing checks for oncology buyers and technical teams.

Lipase inhibitors are enzyme-targeting compounds used in obesity research, assay setup, and active ingredient comparison. This article explains how they work, what public orlistat data shows, and what buyers should check before…

HDAC inhibitors are routine epigenetic research tools, but useful data still depends on isoform choice, assay setup, and chemical quality. This guide looks at inhibitor types for screening, validation, and sourcing work.

A plain guide to EGFR inhibitors, mutation types, public oncology data, and checks to make before ordering research-grade inhibitor compounds.

A plain trade guide to P-gp inhibitors for chemical, pharmaceutical, and research teams working on transporter risk, assay setup, and supplier checks.

A plain trade guide to 3A4 inhibitors for pharma, chemical, and sourcing teams checking CYP3A4 interaction risk, strength classes, and supplier documents.